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Microbial interactions represent an understudied facet of human health and disease.
In this study, the interactions that occur between Chlamydia trachomatis and the
opportunistic fungal pathogen, Candida albicans were investigated. Candida albicans
is a common component of the oral and vaginal microbiota responsible for thrush
and vaginal yeast infections. Normally, Candida exist in the body as yeast. However,
disruptions to the microbiota create conditions that allow expanded growth of Candida,
conversion to the hyphal form, and tissue invasion. Previous studies have shown that
a myriad of outcomes can occur when Candida albicans interacts with pathogenic
bacteria. To determine if C. trachomatis physically interacts with C. albicans, we
incubated chlamydial elementary bodies (EB) in medium alone or with C. albicans
yeast or hyphal forms for 1 h. Following incubation, the samples were formaldehydefixed and processed for immunofluorescence assays using anti-chlamydial MOMP
or anti- chlamydial LPS antibodies. Replicate samples were replenished with culture
medium and incubated at 35◦ C for 0–120 h prior to fixation for immunofluorescence
analysis or collection for EB infectivity assays. Data from this study indicates that both
C. trachomatis serovar E and C. muridarum EB bind to C. albicans yeast and hyphal
forms. This interaction was not blocked by pre-incubation of EB with the Candida cell
wall components, mannan or β-glucans, suggesting that EB interact with a Candida
cell wall protein or other structure. Bound EB remained attached to C. albicans for
a minimum of 5 days (120 h). Infectivity assays demonstrated that EB bound to
C. albicans are infectious immediately following binding (0h). However, once bound to
C. albicans, EB infectivity decreased at a faster rate than EB in medium alone. At 6h
post binding, 40% of EB incubated in medium alone remained infectious compared to
only 16% of EB bound to C. albicans. Likewise, pre-incubation of EB with laminarin,
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a soluble preparation of β-glucan, alone or in combination with other fungal cell wall
components significantly decreases chlamydial infectivity in HeLa cells. These data
indicate that interactions between EB and C. albicans inhibit chlamydial infectivity,
possibly by physically blocking EB interactions with host cell receptors.
Keywords: Chlamydia trachomatis, Candida albicans, bacterial-fungal interactions, co-culture, normal flora,
opportunistic infections

inner layer of the cell wall is primarily composed of β-1,3glucan and β-1,6-glucan. A small portion of the cell wall is
composed of chitin. These structures are critical to the structural
integrity of the C. albicans cell wall in both the yeast and hyphal
forms. Additionally, both mannans and β-glucans are immune
stimulatory molecules that are recognized by a variety of host
pattern recognition receptors, especially C-type lectin receptors
(Gow et al., 2012).
Several previous studies have shown that both symbiotic
and antagonistic Candida/bacterial interactions occur depending
upon the environmental conditions and species involved.
Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter
baumannii as well as several other bacteria have been shown
to inhibit growth of Candida hyphal forms by varying known
and unknown mechanisms (Hogan and Kolter, 2002; Peleg
et al., 2008, 2010). For example, Pseudomonas aeruginosa forms
biofilms on Candida albicans hyphae, but cannot bind to
yeast (Hogan and Kolter, 2002). P. aeruginosa releases several
soluble compounds including phospholipase C, phenazines and
quorum sensing molecules that inhibit the growth of Candida
hyphal forms, decreasing Candida’s virulence (Morales et al.,
2013). Conversely, Candida sp. inhibit the growth of Neisseria
gonorrheae via an unknown mechanism (Kaye and Levison,
1977). Fungal/bacterial interactions can also increase microbial
pathogenesis. Simultaneous infections of E. coli and C. albicans
in mice increased lethality compared to single infections with
either organism (Gale and Sandoval, 1957; Peleg et al., 2010).
Interaction of Streptococcus sp., including pathogenic Group
B Streptococcus, with Candida promotes enhanced biofilm
formation and adhesion to host epithelia (Peleg et al., 2010;
Pidwill et al., 2018). Binding of Staphylococcus to Candida hyphae
promotes dissemination of the bacteria into the blood stream of
mice (Peters et al., 2012; Kong et al., 2015). Other studies suggest
that Candida can serve as a protective reservoir for Helicobacter
pylori, which has been detected in some, albeit not all, instances of
atherosclerosis and Alzheimer’s disease (Honjo et al., 2009; Saniee
and Siavoshi, 2015). Thus, several interesting outcomes have
been documented with C. albicans/bacterial interactions. These
interactions have the potential to: (1) inhibit growth/virulence
of Candida or the bacterial pathogens, (2) provide a reservoir
for bacterial survival within the body, or (3) promote bacterial
dissemination from the site of mucosal infection.
Kelly et al. (2001) demonstrated that concurrent infection
with C. albicans and Chlamydia muridarum did not alter the
immune response or vaginal shedding of either organism in
mice. However, this study did not investigate direct interaction
of the two pathogens in vitro or in a simultaneous in vivo
inoculation (Kelly et al., 2001). Interestingly, dissemination of

INTRODUCTION
Trillions of commensal microbes reside in the human body
at all times. While a diverse microbiota has been correlated
with health, some studies indicate that microbial interactions
can alter the pathogenesis of infection (Baquero and Nombela,
2012; D’Argenio and Salvatore, 2015; Krezalek et al., 2016;
Ziklo et al., 2016). For example, respiratory viruses create
an environment that is favorable for the growth of bacterial
opportunistic pathogens, leading to infections such as otitis
media and bacterial pneumonia (McCullers, 2006; Armbruster
et al., 2010). Co-infection with sexually transmitted pathogens
can increase the transmission of HIV (Rotchford et al.,
2000). Thus, interactions between pathogenic and/or commensal
microbes represent an understudied facet of human health and
disease. In this study, we examined interactions between the
bacterial pathogen, Chlamydia trachomatis and the opportunistic
fungal pathogen, Candida albicans.
Chlamydia trachomatis is the leading bacterial sexually
transmitted infection, causing 1.6 million reported cases in
the United States in 2016 (Centers for Disease Control and
Prevention, 2017). Genital infections with Chlamydia are usually
benign with many being asymptomatic or causing uncomplicated
cervicitis in women and urethritis in men. However, if untreated
these infections can ascend the genital tract leading to pelvic
inflammatory disease, ectopic pregnancy and infertility (Peipert,
2003). Chlamydia are Gram-negative obligate intracellular
bacteria, which exist in the host in two distinct morphological
forms. Transmission occurs when the infectious, condensed,
extracellular form, the elementary body (EB) enters into the host
cell by endocytosis. Once inside the host cell the EB convert to
the non-infectious, intracellular, metabolically active, vegetative
form called the reticulate body (RB). The RB replicate inside of a
modified host vacuole called the inclusion before converting back
into EB. Infectious EB are released from the host cell by host cell
lysis or extrusion and lysis of the inclusion (Elwell et al., 2016).
Candida albicans is a common opportunistic pathogen in the
oral and vaginal microbiota and is responsible for vaginal yeast
infections and thrush (Mayer et al., 2013). Normally, C. albicans
exist in the body as a yeast member of the fungal microbiome.
However, when given the opportunity, such as in the case of
immunosuppression or antibiotic usage, C. albicans can convert
to an invasive hyphal form that damages the mucosal tissue
(Mayer et al., 2013). Invasive Candida infections can lead to
life threatening fungal sepsis in immunosuppressed individuals.
Candida have a complex cell wall. The outer layer of the Candida
cell wall is comprised of mannose polymers, called mannans,
that are bound to proteins embedded in the cell wall. The
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coverslips for 3–6 h in M199 (pH7.5) medium at 37◦ C to
promote hyphal formation. The Candida cultures or plastic
coverslips were overlaid with 3x105 EB or 2SPG. Following
combination of Candida yeast or hyphal cultures with EB, the
samples were incubated at 35◦ C for 1 h. The cultures were then
washed vigorously three times with PBS to remove unbound EB
and fixed with methanol, formaldehyde or glutaraldehyde. In a
subset of experiments, EB were overlaid onto plastic coverslips
and incubated for 1 h at 35◦ C, but the inoculum was not
removed from the well following incubation. This no-wash
(NW) control was replenished with the appropriate medium as
described below and harvested for EB titer analysis. Replicate
samples were replenished with culture medium (M199 ± 5 µg/ml
Amphotericin B or M199 or MEM ± 1 mM glucose-6phosphate/1% FBS) and incubated for 24–120 h before fixation
for IFA or harvest for EB titer analysis. In some experiments, EB
were pre-incubated (1 h, 37◦ C) with fungal cell wall components
(1 mg/ml), mannan, glucan phosphate (β-glucan) or laminarin
alone or in combination prior to incubation with Candida
cultures.

Chlamydia sp. from the site of primary infection to distal sites in
the body has been reported. Chlamydial DNA has been isolated
from the synovial fluid of patients suffering from Chlamydiainduced reactive arthritis (Baillet et al., 2015). Dissemination of
Chlamydia pneumoniae has been associated with atherosclerosis
and Alzheimer’s disease (Kuo and Campbell, 2003; Shima
et al., 2010). The mechanisms chlamydiae use to disseminate
from the site of primary infection throughout the body have
not been fully investigated. Given the myriad of medically
relevant outcomes that have been reported from investigations
of Candida/bacterial interactions and the high probability that
Candida and Chlamydia encounter one another in host genital
tracts, we sought to determine if direct interactions between
C. trachomatis and C. albicans occur.

MATERIALS AND METHODS
Culture of Candida, Chlamydia, and
Cervical Epithelial Cell Lines
Candida albicans SC5314 cultures were routinely cultured
overnight at 30◦ C in YPD (1%yeast extract, 2% peptone, 2%
dextrose). Overnight cultures of C. albicans were washed with
sterile dH2 O and counted before transferring cells to medium
199 [M199 (9.5 g medium with Earles salts and L-glutamine and
without sodium bicarbonate, 18.7 g Tris-HCL in 1L dH2 O, pH 7.5
or pH 4.5) [Mediatech] at 37◦ C. Chlamydia trachomatis Serovar
E and C. muridarum Weiss stocks were prepared in Hec-1B cells
grown in bead culture as previously described (Guseva et al.,
2007). HeLa cells were maintained in Modified Eagle’s Medium
(MEM; Gibco) supplemented with 10% FBS, and gentamicin
(Gibco). Short tandem repeat profiling was performed by the
American Type Culture Collection to authenticate the identity
and/or origin of all cell lines used in this study (data not shown).
All cell lines were tested for Mycoplasma by PCR and found to be
free of contamination (data not shown).

Immunofluorescence Assays and
Confocal Microscopy Analysis
Methanol or formaldehyde-fixed samples were stained with
BioRad anti-MOMP or LPS Pathfinder stain or with a mouse
anti-Chlamydia MOMP antibody (Abcam BIOD)/rabbit-antimouse Alexa Fluor 488 combination. C. albicans was either
stained with aniline blue or visualized by differential interference
contrast (DIC) microscopy. Samples were examined and imaged
using a Zeiss Axiovert microscope and Zen 2012 software.
Intensity of fluorescent staining/area (um2 ) was measured by
imaging 5 random fields from triplicate experiment samples
(n = 15) at 200× magnification using set exposure conditions.
Confocal images of chlamydial inclusions were captured on a
Leica TCS SP8 with Leica LASX software at 1000× magnification.
Imaris imaging and Leica LASX software were used to analyze the
images.

Mannan, β-Glucan, and Laminarin

Transmission Electron Microscopy

Fungal cell wall components, mannan, glucan phosphate
(β-glucan) or laminarin were prepared in ddH2 O (1 mg/ml).
Mannan was isolated from Candida albicans (Kruppa et al.,
2011). The β-glucan phosphate was a kind gift from Dr. David
Williams at East Tennessee State University. It was prepared
from Saccharomyces cerevisiae (Williams et al., 1991). Laminarin
was purchased from Carbosynth, United States. Purification and
activity validation of these biomolecules have been previously
described (Williams et al., 1991; Adams et al., 2008; Kruppa et al.,
2011; Smith et al., 2018).

Candida albicans or C. albicans/C. trachomatis cultures were fixed
with glutaraldehyde in 0.1 M Cacodylate buffer (EM Sciences)
for 24 h. The monolayers were then collected, agar enrobed,
and stained with osmium tetroxide and uranyl acetate before
alcohol and propylene oxide dehydration (Wyrick et al., 1994).
Dehydrated samples were embedded in Spurr’s low viscosity
resin (EM Sciences Kit 14300) to improve penetration of the
medium into the Candida cell wall (Taff and Andes, 2013).
Thin sections were examined on a Tecnai 10 (FEI) transmission
electron microscope operating at 60–80 kV.

Candida/Chlamydia Binding Assay
Percent Infectivity

Candida albicans SC5314 (1 × 105 cells/sample) was cultured
as yeast for 3–6 h in M199 (pH 4.5) medium at 37◦ C. The
yeast were then mixed with 3 × 105 C. trachomatis Serovar E
or C. muridarum EB or 2SPG (0.2 M sucrose, 0.02 M phosphate
buffer, and 5 mM l-glutamine) and plated onto coverslips.
Alternatively, C. albicans was cultured on FBS-coated plastic
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alone or containing 1 mg/ml fungal cell wall components,
mannan, β-glucan, or laminarin alone or in combination.
Following exposure to the cell wall components, HeLa 229 cells
were inoculated with the EB/cell wall component mixtures for
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1h at 35◦ C. The inoculum was aspirated from the infected
cultures and the cells were replenished with MEM+10% FBS.
At 48hpi, the samples were fixed with methanol and stained
for chlamydial inclusions using Pathfinder anti-Chlamydia
MOMP stain (BioRad). Cell nuclei were stained with DAPI
(ThermoFisher). Chlamydial inclusions and host cell nuclei were
visualized on a Zeiss Axiovert Discovery Microscope at 400×
magnification. In each experiment, the number of inclusions and
nuclei were counted in 15 random fields from triplicate samples
and the average percentage of infected cells was calculated per
condition. A high dilution of EB was used in these studies to make
counting the percentage of infected cells more accurate.

processed for IFA to visualize any elementary bodies (EB) bound
to the coverslips or Candida. These experiments demonstrated
that EB bind to Candida hyphal cultures and remain bound
for 24h (Figure 1). No significant difference in chlamydial
staining was observed between samples permeabilized with
methanol or not permeabilized, indicating that the observed
fluorescence was primarily due to binding of EB on the
surface of C. albicans (Figure 1, bottom row). A similar result
was observed with C. muridarum EB binding to C. albicans
(Supplementary Figure 1). In replicate experiments, Ca/CtE
samples were harvested for analysis by confocal and transmission
electron microscopy as described in the methods. For confocal
microscopy we stained Candida with the non-specific stain,
aniline blue. As shown in Figure 2A, EB staining co-localized
with the aniline blue staining of Candida hyphae. The chlamydia
staining indicates that the EB are bound to the surface of
C. albicans as there was a clear separation in the Chlamydia and
Candida staining observed in the digital sections and in crosssections of Ca/CtE samples (Figures 2B,C). TEM images also
demonstrate that EB (Figures 2E–G, yellow arrows) bind to the
surface of the Candida cell wall (Figures 2D–G, white arrows).
Data from these imaging analyses support the IFA data, which
indicate that Chlamydia EB bind to the surface of C. albicans
hyphae.
As C. albicans usually exists in vivo in the yeast form,
we examined the ability of EB to bind to C. albicans yeast.
Yeast cultures or medium alone was mixed with EB or 2SPG
in suspension for 1h prior to plating the samples onto FBScoated coverslips. The yeast were then allowed to attach to the
coverslips for 1h before the cultures were washed, replenished
with medium, and incubated for 0–120 h (1–5 days) before
fixation and IFA analysis. In duplicate samples we repeated the
Candida hyphae/EB binding study described above, harvesting
the cultures 0–120 h (1–5 days) for IFA analysis. In both
experiments, a replicate set of Ca/CtE cultures were exposed
to Amphotericin B to inhibit overgrowth of the Candida
biofilm. Data from these studies indicate that EB bound to both
C. albicans yeast and hyphal forms and remained bound for a
minimum of 5 days (120 h, Supplementary Figure 2). Continued
binding was most evident in samples in which new Candida
growth was limited by Amphotericin B.

EB Titer Analysis
Triplicate C. albicans, C. trachomatis, C. albicans/C. trachomatis
cultures, prepared as described in section “Candida/Chlamydia
Binding Assay”, were scraped into the culture medium and
frozen at −80◦ C. EB released from the cells by freeze/thaw
and sonication were diluted in culture medium (MEM +
10%FBS, 0.5 µg/ml cycloheximide, gentamicin, and 5 µg/ml
amphotericin B) and used to infect HeLa 229 monolayers grown
on coverslips by spin infection (1 h, 1100 × g). Triplicate
infected monolayers were incubated for 48 h at 35◦ C before
methanol fixation and staining with Pathfinder anti-Chlamydia
MOMP stain (BioRad). Total inclusions were counted on each
coverslip using a Zeiss Axiovert Discovery Microscope at 200x
magnification. The average number of inclusion forming units
(IFU)/ml was calculated per sample and experimental condition.

Statistical Analysis
All experiments contained three biological replicates and were
independently repeated a minimum of three times. Values from
independent experiments were averaged and presented as the
mean ± the standard error of the mean (SEM). Means were
compared by Analysis of Variance (ANOVA) and independent
two-sample T-tests using MiniTab Version 17 Statistical Software
and Microsoft Excel. Comparisons with p-values ≤ 0.05 were
considered significantly different.

RESULTS
Chlamydia Elementary Bodies Bind to
the Surface of Candida albicans Yeast
and Hyphal Forms

Chlamydia Elementary Bodies Bound to
the Surface of Candida albicans Lose
Infectivity

We sought to determine if Chlamydia EB physically interacts
with C. albicans by examining EB binding to yeast or hyphal
forms. We first assessed EB binding to Candida hyphal forms.
Candida yeast or medium alone was seeded onto FBS-coated
coverslips and incubated for 3h under conditions that promote
hyphal formation. The Candida cultures were then overlaid with
C. trachomatis serovar E EB or 2SPG such that Chlamydia (CtE),
Candida (Ca) and Candida albicans/Chlamydia trachomatis
(Ca/CtE) samples were prepared. Following incubation, the
cultures were washed, replenished with medium and incubated
for 24h before fixation with methanol or formaldehyde and

We next wanted to determine if EB bound to Candida remained
infectious. To accomplish this, we set up Candida hyphae/EB
binding studies as described above in section “Chlamydia EB
Bind to the Surface of Candida albicans Yeast and Hyphal
Forms” and the methods. Following the incubation period, the
cultures were washed and replenished with either M199 or
MEM culture medium. M199 is the standard culture medium
used for C. albicans culture, whereas MEM is typically used for
C. trachomatis culture. We chose to replicate the experiments
using both types of media so that no experimental artifacts would
be observed due to the use of a medium that is not commonly
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FIGURE 1 | Chlamydia trachomatis EB bind to the surface of Candida albicans. FBS-coated coverslips were inoculated with C. albicans or medium alone and
incubated 3 h prior to exposure to EB (Ca/CtE or CtE) or 2SPG (Ca). Following incubation of 1 h, the cultures were washed, replenished with medium and incubated
for 24 h before collection for IFA by fixation with methanol or formaldehyde (No permeabilization). Samples were stained with Pathfinder anti-Chlamydia MOMP stain
and visualized 100× magnification.

which has been shown to promote EB viability (Omsland et al.,
2012). However, this did not restore or significantly prolong
EB infectivity once they were bound to C. albicans hyphal
cultures (Figure 3). Control samples were included in these
experiments, in which the chlamydial EB were not removed
and washed away following the hour adsorption period. The
controls were replenished with MEM or MEM+G6P/FBS and
examined by titer analysis to determine if the EB remained
viable in the medium of the course of the experiment. Data
from the control samples indicate that 49–79% of EB remained
viable in MEM or MEM+G6P/FBS for 6h in the absence of
Candida (Supplementary Figure 3). These data suggest that
specific EB/Candida interactions are responsible for the observed
decrease in chlamydial infectivity.

used for either pathogen. Ca, CtE and Ca/CtE cultures were
harvested for IFA and EB titer analysis at 0, 1, and 3 days
post incubation (Figures 3A,B). As expected, no inclusions
were found in Candida alone samples. On day 0, there were
significantly more infectious EB recovered from the Ca/CtE
cultures than the CtE alone. These data again confirm EB
binding (Figure 3A) to Candida and also indicate that EB remain
infectious immediately following binding (Figure 3B). However,
by 24h (day 1) post incubation EB bound to Candida are no
longer infectious (Figure 3B). In fact, EB bound to Candida
lose a significant amount of infectivity within the first 6h of
binding (Figures 3C–E). Remarkably, EB bound to Candida lost
infectivity at an increased rate compared to EB bound to the
coverslip alone. At 6h post binding, 40% of EB incubated in
medium alone remained infectious compared to only 16% of EB
bound to C. albicans (Figure 3E).
Previous studies have shown that maximal viability of
C. trachomatis EB and RB is dependent on availability of
specific energy sources. Omsland et al. (2012) demonstrated
that EB require glucose-6-phosphate as an energy source. We
wanted to ensure that the observed loss of infectivity by
Candida bound EB was not simply due to depletion of EB
specific energy sources over time. Therefore, we repeated the
studies described above using M199 or MEM supplemented with
glucose-6-phosphate and 1% FBS (M199 or MEM+G6P/FBS),
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Interaction of Chlamydia Elementary
Bodies With a Soluble β-Glucan,
Laminarin, Inhibits Chlamydial Infectivity
in HeLa Cells
Interactions of Chlamydia with the surface of Candida could
be mediated via numerous Candida cell wall protein or
polysaccharide structures. Mannose polymers, mannans, linked
to cell wall proteins, as well as 1,3 and 1,6 linked β-glucans
comprise a substantial portion of the Candida cell wall.
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FIGURE 2 | Confocal and transmission electron microscopy imaging of C. albicans/C. trachomatis cultures. C. albicans hyphal cultures were prepared alone or
exposed to EB and processed for IFA and TEM visualization as described in the methods. (A) Confocal image of Ca/CtE culture at 100x magnification. (B) Individual
Z sections taken at 30 micron intervals throughout the depth of the sample. Bottom denotes the coverslip. (C) Cross-section of the confocal image presented in (A).
Green: Pathfinder anti-Chlamydia MOMP stain, Red: Aniline blue stain for Candida. (D) TEM micrograph of Ca culture at 7000× magnification. (E) TEM micrograph
of Ca/CtE culture at 7000× magnification. (F,G) TEM micrographs of Ca/CtE cultures at 20000× magnification. Yellow Arrows: C. trachomatis EB, White Arrows:
Candida cell wall.

binding to C. albicans. However, laminarin exposure modestly
decreased chlamydial staining intensity, suggesting it may have a
partial effect on binding (Figures 4A,B). In similar experiments,
HeLa monolayers were infected with C. trachomatis following
pre-incubation with diluent, mannan, β-glucan and laminarin
alone or in combination. The infected HeLa cultures were
harvested for analysis of inclusion development by measuring
percent infectivity at 48hpi. Interestingly, pre-incubation of EB
with laminarin alone or in combination with β-glucan and
mannan significantly decreased chlamydial inclusion formation
(Figure 4C, p ≤ 0.01) compared to the diluent control.
Additionally, we did not observe EB bound to the surface
of infected HeLa cells in these experiments, suggesting that
laminarin pre-exposure blocked attachment and entry of EB to
the epithelial cells (Supplementary Figure 4). These data indicate
that interaction of EB with soluble fungal cell wall carbohydrates
does not block EB binding to C. albicans, but these interactions
do inhibit chlamydial infectivity.

Furthermore, these structures are found on both yeast and
hyphae (Gow et al., 2012; Lowman et al., 2014). Given that
we observed EB binding to both of Candida’s morphological
forms, these common cell wall structures seemed good candidates
for chlamydial binding targets. To examine this possibility,
C. trachomatis EB were incubated with soluble fungal cell
wall components, glucan-phosphate (β-glucan), a commercial
preparation of β-glucans called laminarin, or mannan alone or
in combination for 1hr (Williams et al., 1991; Adams et al.,
2008; Kruppa et al., 2011). Following exposure to the cell wall
components, EB were overlaid onto C. albicans hyphal cultures
prepared as described above. The Ca/CtE cultures were fixed
and stained for EB visualization by IFA. Binding of EB to
Candida was quantified by measuring the fluorescence intensity
of chlamydial antibody staining in Ca/CtE cultures prepared
with EB exposed to the diluent, mannan, β-glucan or laminarin.
Data from these studies indicate that exposure to mannan,
β-glucan or laminarin did not significantly block C. trachomatis
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FIGURE 3 | Binding to Candida albicans decreases C. trachomatis EB infectivity. FBS-coated coverslips were inoculated with C. albicans or medium alone and
incubated 3h prior to exposure to EB (Ca/CtE or CtE) or 2SPG (Ca). Following incubation of 1h, the cultures were washed, replenished with MEM or M199
medium ± G6P/FBS. Duplicate sets of samples were fixed and processed for IFA or harvested for EB titer analysis at various times post incubation. (A) IFA of
Ca/CtE at Day 0, 1, and 3 post incubation in M199 ± G6P/FBS. Chlamydia EB -Red: mouse anti-Chlamydia MOMP/rabbit-anti-mouse Alexa Fluor 594, Candida:
DIC 200x magnification. (B) EB titers from Ca, CtE and Ca/CtE cultures at Day 0, 1, and 3 post incubation in M199 ± G6P/FBS. EB titers form CtE and Ca/CtE
cultures harvested at 0 and 6h post incubation in MEM (C) or MEM+G6P/FBS (D). (E) Percentage of IFU/ml remaining 6h post incubation compared to 0h for CtE
and Ca/CtE cultures in MEM ± G6P/FBS. The data shown represent the means ± SEM of three independent repeats with 3 biological replicates/repeat (n = 9). An
asterisk (∗ ) indicates a significant difference between CtE and Ca/CtE (p ≤ 0.05) as determined by ANOVA and two-sample independent T-tests.

However, studies have demonstrated that Chlamydia-infected
women are readily colonized with Candida (Jespers et al., 2014;
Van Der Pol et al., 2018). Likewise, Kelly, et al. did not observe
an effect on vaginal shedding, or immune response to either
organism in mice during concurrent infection (Kelly et al., 2001).
These studies suggest that simultaneous Candida colonization
may not negatively impact Chlamydia infections in vivo. This
could be due to differences in the number and/or location
of each organism in the genital tract. For example, vaginal
Candida colonization might have less opportunity to influence
an established Chlamydia infection in the endometrium. We
also observed chlamydial inhibition specifically with laminarin,
a soluble preparation of β-glucan. β-glucans are primarily located
in the inner layer of the Candida cell wall (Gow et al., 2012).
Surface exposure of β-glucans does occur, but it is limited
to nanoscopic size areas of the cell wall (Graus et al., 2018).
Additionally, chlamydial infections in vivo occur in the presence
of seminal fluid, vaginal secretions and additional members of
the vaginal microbiota. Semen is known to enhance transmission
of human immunodeficiency virus (Lump et al., 2015; Roan
and Münch, 2015). Both semen and the vaginal microbiota

DISCUSSION
Pathogens do not exist in isolation in the genital tract (Lamont
et al., 2011). They interact with members of the microbiome as
well as neighboring pathogens. There are numerous examples
demonstrating that these interactions can influence pathogenesis
to benefit or harm the host or the respective microbes (Peleg et al.,
2010; Baquero and Nombela, 2012; Mayer et al., 2013; D’Argenio
and Salvatore, 2015; Kong et al., 2015 ). Here we present a
novel mechanism of chlamydial inhibition by interactions with
a common member of the fungal microbiome and opportunistic
pathogen, Candida albicans. We demonstrated that EB bind
C. albicans yeast and hyphal morphological forms. Binding
to C. albicans significantly decreased C. trachomatis’ ability to
infect human cervical epithelial cells. Moreover, we found that
interaction of C. trachomatis EB with a soluble preparation of
β-glucan, a major component of C. albicans cell walls, diminishes
chlamydial inclusion development in vitro. This is an exciting
observation, suggesting that direct binding of chlamydial EB to
Candida or interaction with shed Candida cell wall components
may inhibit C. trachomatis disease progression.
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FIGURE 4 | The impact of EB interactions with fungal cell wall components on C. albicans binding and infectivity in HeLa cells. C. trachomatis EB were incubated
with diluent (H2 O) or fungal cell wall components, mannan (Man), β-glucan (βglu) or laminarin (Lam) for 1h at 37◦ C prior to incubation with 3h old C. albicans hyphal
cultures (A,B) or inoculation of HeLa cell monolayers (C) as described in the methods. (A) Following incubation, Ca/CtE cultures were harvested for IFA. ChlamydiaRed: mouse anti-Chlamydia MOMP/rabbit-anti-mouse Alexa Fluor 594, Candida: DIC 200× magnification. (B) Average intensity/um2 of chlamydia staining
represented in panel (A). (C) The percentage of HeLa cells infected with EB exposed to diluent or fungal cell wall component alone or in combination. The data
shown represent the means ± SEM of three independent repeats with 3 biological replicates/repeat (n = 9). An asterisk (∗ ) indicates a significant difference between
the experimental sample and the diluent control (p ≤ 0.05) as determined by ANOVA and two-sample independent T-tests.

surface receptor that is required for chlamydial attachment or
entry. It is also possible that because laminarin was not removed
from the inoculum, inhibition of C. trachomatis may be due to
laminarin-induced host cell signaling pathways that negatively
impact chlamydial growth. Regardless of the mechanism,
laminarin had a strong inhibitory effect on C. trachomatis.
This interesting observation opens up the possibility that
laminarin could be used as a tool for determining the identity
and specific functions of unknown chlamydial adhesins that are
required for host cell infection. Others have noted that laminarin
possesses antimicrobial properties (Pérez et al., 2016). The
results presented here suggest that laminarin may function as an
anti-chlamydial compound. Furthermore, β-glucan activation
of Dectin-1 is a known mechanism of innate immune training
(Cheng et al., 2014; Quintin et al., 2014; van der Meer et al.,
2015). Studies have shown that innate immune training by
β-glucan/Dectin-1 signaling confers non-specific protective
effects against subsequent infections (Cheng et al., 2014; Quintin
et al., 2014; van der Meer et al., 2015). Thus, theoretically, a
β-glucan-based microbicide would have the potential to elicit
an immune response in the genital tract that protects the host
from infection with C. trachomatis or other sexually transmitted
pathogens. While these possibilities are very intriguing, we
must note a limitation of this study. The inhibitory effects of
Candida/Chlamydia binding and laminarin pre-exposure were
examined using a laboratory strain of Chlamydia trachomatis
Serovar E. It is possible that clinical isolates will vary in
their interactions with C. albicans and/or laminarin. Future

have been shown to impact the effectiveness of anti-HIV
microbicides (Roan and Münch, 2015; Taneva et al., 2018). Thus,
it is possible that: 1) there are not sufficient opportunities for
direct inhibitory interaction between EB and Candida in vivo
to significantly decrease C. trachomatis infection rates; or 2)
chemical and/or physical properties of the in vivo environment
prevent C. trachomatis inhibition by C. albicans.
Still, we demonstrated that a commercial preparation of
β-glucan was sufficient to inhibit Chlamydia trachomatis
infection in culture. Laminarin is a soluble form of β-glucan
isolated from the algae, Eisenia bicyclis. It contains short
1,3 linked polysaccharides with minimal 1,6 linked branches.
Laminarin has been shown to have a wide range of beneficial
properties including tumor inhibition, and the ability to act as
an antioxidant or anticoagulant (Miao et al., 1995; Ji et al., 2013;
Smith et al., 2018). Most notable though, is its ability to stimulate
the immune response. β-glucans activate cytokine production
via the C-type lectin receptor, Dectin-1 (Smith et al., 2018).
Numerous reports indicate that laminarin has either agonistic or
antagonistic effects on Dectin-1 activity. The specific preparation
used in this study is a Dectin-1 agonist (Smith et al., 2018).
Pre-exposure of C. trachomatis EB to laminarin: (1)
modestly decreased Candida/Chlamydia binding, and (2)
inhibited inclusion development in HeLa cells. Several possible
mechanisms could be responsible for these observations. First,
the physical interactions between EB surface molecules and
laminarin may block chlamydial adhesins needed for entry into
the host cell. Alternatively, laminarin may bind to host cell
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studies are needed to fully investigate the consequences of
Chlamydia trachomatis interactions with its fungal neighbor,
Candida albicans, and the inhibitory actions of laminarin on
chlamydial infections.
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